top of page
SelenBio, Inc.
Login to favorite a company
SelenBio, Inc. is a biotechnology company developing antibacterial technology for a wide variety of use cases.
Most Recent Valuation:
$19,709,500.00
Legal Name:
Founded:
State of HQ:
SelenBio, Inc
2/24/2017
TX
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
1
Total amount raised
$147,972
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
SelenBio, Inc. Stock 1 | 04/28/2020 | $147,972.00 | closed | Common Stock | $100 | $19,709,500 | 4 |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page